Cetera Investment Advisers
TEVA icon

Cetera Investment Advisers’s Teva Pharmaceuticals TEVA Stock Holding History

Cetera Investment Advisers’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.9M Sell
85,581
-1,635
-2% -$54.5K ﹤0.01% 2073
2026
Q1 		$2.63M Buy
87,216
+26,789
+44% +$862K ﹤0.01% 2032
2025
Q4 		$1.89M Buy
60,427
+13,212
+28% +$325K ﹤0.01% 2258
2025
Q3 		$954K Buy
47,215
+7,840
+20% +$138K ﹤0.01% 2801
2025
Q2 		$660K Sell
39,375
-15,055
-28% -$243K ﹤0.01% 2742
2025
Q1 		$837K Buy
54,430
+1,325
+2% +$23.7K ﹤0.01% 2408
2024
Q4 		$1.17M Sell
53,105
-899
-2% -$16.4K ﹤0.01% 2058
2024
Q3 		$973K Sell
54,004
-6,864
-11% -$120K ﹤0.01% 2145
2024
Q2 		$989K Buy
60,868
+27,765
+84% +$428K ﹤0.01% 2084
2024
Q1 		$467K Buy
33,103
+8,629
+35% +$109K ﹤0.01% 2658
2023
Q4 		$256K Sell
24,474
-3,711
-13% -$34.6K ﹤0.01% 1885
2023
Q3 		$287K Sell
28,185
-4,642
-14% -$43.2K ﹤0.01% 1757
2023
Q2 		$247K Buy
32,827
+318
+1% +$2.58K ﹤0.01% 1864
2023
Q1 		$288K Sell
32,509
-1,328
-4% -$13.1K ﹤0.01% 1731
2022
Q4 		$309K Buy
33,837
+14,306
+73% +$125K ﹤0.01% 1652
2022
Q3 		$158K Sell
19,531
-17,790
-48% -$157K ﹤0.01% 1530
2022
Q2 		$281K Sell
37,321
-375
-1% -$3.27K ﹤0.01% 1460
2022
Q1 		$354K Buy
37,696
+9
+0% +$75 0.01% 1387
2021
Q4 		$302K Buy
37,687
+660
+2% +$5.96K ﹤0.01% 1488
2021
Q3 		$361K Sell
37,027
-698
-2% -$6.54K 0.01% 1320
2021
Q2 		$373K Buy
37,725
+1,388
+4% +$14.7K 0.01% 1287
2021
Q1 		$419K Sell
36,337
-3,681
-9% -$42.2K 0.01% 1076
2020
Q4 		$386K Buy
+40,018
New +$383K 0.01% 1099
2017
Q3 		– Sell
-11,168
Closed -$373K – 410
2017
Q2 		$373K Buy
+11,168
New +$346K 0.09% 271

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return

Cetera Investment Advisers's TEVA Position: Q2 2026 in Review

Cetera Investment Advisers reduced its Teva Pharmaceuticals (TEVA) stake by 1.9% in Q2 2026, selling an estimated $54.5K and leaving 85,581 shares worth $2.9M. The position accounts for ﹤0.01% of the portfolio, ranked #2073.

Cetera Investment Advisers first reported a position in TEVA in Q2 2017 and has held it in 24 quarters since. 672 funds tracked by Wall St. Rank hold TEVA as of Q2 2026.

  • Cetera Investment Advisers held 85,581 shares of Teva Pharmaceuticals worth $2.9M as of Q2 2026.
  • Cetera Investment Advisers sold 1,635 Teva Pharmaceuticals shares in Q2 2026, an estimated $54.5K.
  • Teva Pharmaceuticals made up ﹤0.01% of Cetera Investment Advisers's portfolio in Q2 2026, its #2073 holding.
  • Cetera Investment Advisers first reported a position in Teva Pharmaceuticals in Q2 2017 and has held it in 24 quarters since.
  • 672 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q2 2026.

Based on Cetera Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.